Krystal Biotech, Inc.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US5011471027
USD
221.96
6.9 (3.21%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
290.51
50.70
0.00
0.00
0.00
0.00
0.00
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
290.51
50.70
0.00
0.00
0.00
0.00
0.00
Raw Material Cost
26.81
8.10
4.05
2.77
1.85
0.97
0.14
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
106.94
93.39
76.28
39.42
13.21
5.49
4.01
Other Expenses
5.36
4.64
3.99
2.61
1.79
1.56
0.78
Total Expenditure (Excl Depreciation)
187.32
147.93
120.20
68.28
33.00
22.08
11.92
Operating Profit (PBDIT) excl Other Income
103.2
-97.2
-120.19999999999999
-68.3
-33
-22.1
-11.899999999999999
Other Income
29.66
122.62
5.22
-1.29
0.83
2.99
1.03
Operating Profit (PBDIT)
139.60
30.40
-110.92
-66.80
-30.32
-18.11
-10.75
Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Exceptional Items
-37.50
-12.50
-25.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
263.71
42.60
-4.05
-2.77
-1.85
-0.97
-0.14
Depreciation
6.75
5.01
4.05
2.77
1.85
0.97
0.14
Profit Before Tax
95.36
12.90
-139.97
-69.57
-32.17
-19.09
-10.89
Tax
6.20
1.97
0.00
0.00
0.00
0.00
0.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
89.16
10.93
-139.97
-69.57
-32.17
-19.09
-10.89
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
89.16
10.93
-139.97
-69.57
-32.17
-19.09
-10.89
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
89.16
10.93
-139.97
-69.57
-32.17
-19.09
-10.89
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
946.38
778.64
522.23
593.58
292.08
202.91
113.23
Earnings per share (EPS)
3.0
0.39
-5.49
-3.13
-1.71
-1.2
-0.97
Diluted Earnings per share
3.0
0.39
-5.49
-3.13
-1.71
-1.2
-0.97
Operating Profit Margin (Excl OI)
35.52%
-191.77%
0.0%
0.0%
0.0%
0.0%
0.0%
Gross Profit Margin
35.15%
35.31%
0.0%
0.0%
0.0%
0.0%
0.0%
PAT Margin
30.69%
21.56%
0.0%
0.0%
0.0%
0.0%
0.0%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 472.98% vs 0.00% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is 718.35% vs 107.79% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is 219.20% vs 20.59% in Dec 2023

stock-summary

Interest

No Interest in the last few periods

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has improved from Dec 2023

Compare Annual Results Of Krystal Biotech, Inc. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
Net Sales
290.51
385.69
-95.18
-24.68%
Other Operating Income
0.00
0.00
0.00
Total Operating income
290.51
385.69
-95.18
-24.68%
Raw Material Cost
26.81
41.26
-14.45
-35.02%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0.00
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
0.00
21.58
-21.58
-100.00%
Selling and Distribution Expenses
106.94
410.32
-303.38
-73.94%
Other Expenses
5.36
16.50
-11.14
-67.52%
Total Expenditure (Excl Depreciation)
187.32
638.13
-450.81
-70.65%
Operating Profit (PBDIT) excl Other Income
103.19
-252.44
355.63
140.88%
Other Income
29.66
15.01
14.65
97.60%
Operating Profit (PBDIT)
139.60
-229.47
369.07
160.84%
Interest
0.00
21.58
-21.58
-100.00%
Exceptional Items
-37.50
-28.12
-9.38
-33.36%
Gross Profit (PBDT)
263.71
344.43
-80.72
-23.44%
Depreciation
6.75
7.96
-1.21
-15.20%
Profit Before Tax
95.36
-287.13
382.49
133.21%
Tax
6.20
0.09
6.11
6,788.89%
Provisions and contingencies
0
0
0.00
Profit After Tax
89.16
-287.22
376.38
131.04%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
89.16
-287.22
376.38
131.04%
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
89.16
-287.22
376.38
131.04%
Equity Capital
0
0
0.00
Face Value
0.00
0.00
0.00
Reserves
946.38
57.02
889.36
1,559.73%
Earnings per share (EPS)
3.00
-5.99
8.99
150.08%
Diluted Earnings per share
3.00
-5.99
8.99
150.08%
Operating Profit Margin (Excl OI)
35.52%
-65.45%
0.00
100.97%
Gross Profit Margin
35.15%
-72.38%
0.00
107.53%
PAT Margin
30.69%
-74.47%
0.00
105.16%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 29.05 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 472.98% vs 0.00% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 8.92 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 718.35% vs 107.79% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 10.99 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 219.20% vs 20.59% in Dec 2023

Annual - Interest
Markets Mojo
No Interest in the last few periods
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 35.52%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has improved from Dec 2023